Exploring key regulators of programmed cell death in melanoma and the immune system’s response
A new paper published in the journal Nature Communications explores programmed cell death (PD-1) in melanoma cells and the immune system’s response.
Noticias
Study reveals molecular mechanism behind multiple sclerosis and other autoimmune diseases
More than two decades ago, a research team in the lab of David Hafler, a Yale researcher who at the time was at Harvard, discovered a type of T cell in humans that suppresses the immune system; they later found that these so-called regulatory T cells, …
New pancreatic cancer treatment proves effective in shrinking, clearing tumors
Researchers at the University of Massachusetts Amherst and UMass Chan Medical School have demonstrated in mice a new method to combat pancreatic cancer. The study, published in Science Translational Medicine, outlines the synergistic effects of a novel…
Discovery of how blood clots harm brain and body in COVID-19 points to new therapy
In a study that reshapes what we know about COVID-19 and its most perplexing symptoms, scientists have discovered that the blood coagulation protein fibrin causes the unusual clotting and inflammation that have become hallmarks of the disease, while al…
Findings suggest common salt activates anti-tumor cells
Salt could help to boost the immune defense against cancer. This is suggested by the research findings of a team led by Prof. Dr. Christina Zielinski, who holds the Chair of Infection Immunology at the Friedrich Schiller University in Jena. The group p…
Multipurpose vaccine shows new promise in the presence of pre-existing immunity
As researchers estimate that nearly all Americans have been exposed to SARS-CoV-2, the virus that causes COVID-19, whether through infection or vaccination, we are no longer “immunologically naive”—in other words, our immune systems are familiar with c…
Researchers identify immune profile for lung disease caused by allergic reaction
Fibrotic hypersensitivity pneumonitis is a chronic and progressive interstitial lung disease, caused by an immune response to inhaled foreign antigens or allergens. Researchers from Yale’s Section of Pulmonary, Critical Care and Sleep Medicine have use…
New drug combinations could improve therapies for breast cancer, other aggressive cancers
Oregon Health & Science University researchers have identified a combination of treatments that show promise in slowing the progression of cancer and reducing tumor growth. Their research lays the groundwork for developing more effective treatments for…
Colorectal cancer: New approach for better efficacy of immunotherapies
The most common form of colorectal cancer, microsatellite-stable colorectal cancer (MSS CRC), can currently only be treated to a limited extent with modern immunotherapies. A research team led by MedUni Vienna has now identified the possible cause of t…
Synthetic immunology: Approaching a turning point in the treatment and prevention of disease
Synthetic immunology, an innovative field of research that could lead to fundamentally new approaches and methods in the treatment of infectious diseases and cancer, is the topic of a new article published in Nature Nanotechnology.